Director, Clinical Pharmacology and Pharmacometrics
AstraZeneca
Dr. Venkatesh Pilla Reddy is a Director, Clinical Pharmacology and Quantitative Pharmacology function of AstraZeneca, Cambridge UK. He obtained his PhD in Pharmacometrics through a unique industry collaboration program between Pfizer, Janssen Pharmaceuticals and Merck via TI Pharma in the Netherlands. His PhD work was focused on PKPD M&S of antipsychotic drugs. He subsequently worked at Quantitative Pharmacology and Pharmacometrics group in Merck & Co before joining AstraZeneca Early Oncology function. Venkatesh provided Model-Informed Drug Development support to various oncology projects. He has been influential in gaining acceptance and addressing questions from regulatory agencies for Olaparib and Osimertinib programs. He has participated on MIDD related panel discussion with the European Medicines Agency and the US Food and Drug Administration (FDA). Venkatesh currently holds the Deputy Topic Leader position at the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) Management Committee to work on the ICH M12 DDI guidelines, and co‐leads various cross‐industry working groups such as IQ TALG, ISOP and ISSX M&S. Over 15 years of his industry carrier, he has published > 40 peer review research articles, 2 book chapters. He presented >15 invited oral presentations at international quantitative clinical pharmacology, QSP and PKPD/PBPK events, and supervised a post-doc and 4 graduate students.
Disclosure information not submitted.
Monday, April 25, 2022
8:00 AM – 1:30 PM ET
.png)